Cargando…

Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy

Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shu-Ting, Xu, Dan, Liao, Ru-Fang, Luo, Jia-Zhen, Liu, Yu-Hang, Qi, Zhen-Hua, Zhang, Cai-Ju, Ye, Nai-Li, Wu, Bo, Xu, Hai-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517535/
https://www.ncbi.nlm.nih.gov/pubmed/31193098
http://dx.doi.org/10.1016/j.csbj.2019.04.005
_version_ 1783418297152176128
author Lu, Shu-Ting
Xu, Dan
Liao, Ru-Fang
Luo, Jia-Zhen
Liu, Yu-Hang
Qi, Zhen-Hua
Zhang, Cai-Ju
Ye, Nai-Li
Wu, Bo
Xu, Hai-Bo
author_facet Lu, Shu-Ting
Xu, Dan
Liao, Ru-Fang
Luo, Jia-Zhen
Liu, Yu-Hang
Qi, Zhen-Hua
Zhang, Cai-Ju
Ye, Nai-Li
Wu, Bo
Xu, Hai-Bo
author_sort Lu, Shu-Ting
collection PubMed
description Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh X-ray attenuation coeffcient was developed and evaluated as a simple but powerful theranostic nanomaterals and potent light-to-heat conversion efficiency for photoacuostic imaging (PAI)/photothermal therapy (PTT) in this study. The prepared pure Bi NPs showed excellent photothermal performance and the temperature of NPs solution (1 mg/mL) increased to 70 °C under near-infrared light irradiation within 4 min. The pure Bi NPs showed obvious enhancement effect both in X-ray computed tomography (CT) and PA imaging modalities in vivo. In addition, the glioma growth was efficiently suppressed by the pure Bi NPs after 808 nm laser irradiation, while maintained the biosafety and low toxicity. Thus, it is notable that this type of Bi nanomaterial has great potential in multi-imaging guided cancer treatment.
format Online
Article
Text
id pubmed-6517535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-65175352019-05-23 Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy Lu, Shu-Ting Xu, Dan Liao, Ru-Fang Luo, Jia-Zhen Liu, Yu-Hang Qi, Zhen-Hua Zhang, Cai-Ju Ye, Nai-Li Wu, Bo Xu, Hai-Bo Comput Struct Biotechnol J Research Article Single-component nanomaterials such as bismuth (Bi) based on nanoparticles (NPs) intrinsically having both diagnostic and therapeutic capabilities are widely needed in biomedical fields. However, their design and fabrication still face enormous challenges. Here, a kind of pure Bi NPs with ultrahigh X-ray attenuation coeffcient was developed and evaluated as a simple but powerful theranostic nanomaterals and potent light-to-heat conversion efficiency for photoacuostic imaging (PAI)/photothermal therapy (PTT) in this study. The prepared pure Bi NPs showed excellent photothermal performance and the temperature of NPs solution (1 mg/mL) increased to 70 °C under near-infrared light irradiation within 4 min. The pure Bi NPs showed obvious enhancement effect both in X-ray computed tomography (CT) and PA imaging modalities in vivo. In addition, the glioma growth was efficiently suppressed by the pure Bi NPs after 808 nm laser irradiation, while maintained the biosafety and low toxicity. Thus, it is notable that this type of Bi nanomaterial has great potential in multi-imaging guided cancer treatment. Research Network of Computational and Structural Biotechnology 2019-04-13 /pmc/articles/PMC6517535/ /pubmed/31193098 http://dx.doi.org/10.1016/j.csbj.2019.04.005 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Lu, Shu-Ting
Xu, Dan
Liao, Ru-Fang
Luo, Jia-Zhen
Liu, Yu-Hang
Qi, Zhen-Hua
Zhang, Cai-Ju
Ye, Nai-Li
Wu, Bo
Xu, Hai-Bo
Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title_full Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title_fullStr Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title_full_unstemmed Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title_short Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
title_sort single-component bismuth nanoparticles as a theranostic agent for multimodal imaging-guided glioma therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517535/
https://www.ncbi.nlm.nih.gov/pubmed/31193098
http://dx.doi.org/10.1016/j.csbj.2019.04.005
work_keys_str_mv AT lushuting singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT xudan singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT liaorufang singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT luojiazhen singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT liuyuhang singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT qizhenhua singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT zhangcaiju singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT yenaili singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT wubo singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy
AT xuhaibo singlecomponentbismuthnanoparticlesasatheranosticagentformultimodalimagingguidedgliomatherapy